The lightning-fast development of COVID-19 vaccines just months after the virus appeared was a triumph of modern science and saved millions of lives. But for all the good they did in reducing illnesses and deaths, the shots ...
Jul 31, 2024
0
67
All safe consumption sites should receive government funding for supervised inhalation. This way, the growing number of people who inhale substances will be closer to the help they need in case of drug poisoning. They'll ...
Jul 29, 2024
0
0
A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created a humanized mouse model ...
Jul 8, 2024
0
71
Earlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza.
Jun 15, 2024
0
0
At the start of the pandemic, many people living with diabetes were wondering what COVID-19 meant for them. Diabetes was already known to put people at higher risks from other infectious diseases, including flu. Would it ...
Jun 6, 2024
0
5
Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that SARS-CoV-2, the virus that causes COVID-19, can remain in the sperm of patients for up to 90 days after hospital discharge and ...
Jun 4, 2024
0
119
On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool may help identify newborns at highest risk for developing serious RSV LRTI, ...
May 21, 2024
0
0
Two new COVID-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter's dominant strain ahead of a possible summer uptick in coronavirus infections.
May 13, 2024
0
23
A defining development of the 20th century that changed the course of public health was when governments around the world improved access to safe water, sanitation and hygiene. However, a binational study led by University ...
May 9, 2024
0
0
Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition that has become the central focus of a class-action lawsuit worth potentially $125 ...
May 1, 2024
0
4
